These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Vogt-Koyanagi-Harada Disease Exacerbation Associated with COVID-19 Vaccine. De Domingo B, López M, Lopez-Valladares M, Ortegon-Aguilar E, Sopeña-Perez-Argüelles B, Gonzalez F. Cells; 2022 Mar 16; 11(6):. PubMed ID: 35326462 [Abstract] [Full Text] [Related]
5. A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy. Minami K, Egawa M, Kajita K, Murao F, Mitamura Y. Case Rep Ophthalmol; 2021 Mar 16; 12(3):952-960. PubMed ID: 35082654 [Abstract] [Full Text] [Related]
6. Clinical features, diagnosis, and management of COVID-19 vaccine-associated Vogt-Koyanagi-Harada disease. Xu K, Gao B, Li J, Xiang Y, Cao L, Zhao M. Hum Vaccin Immunother; 2023 Aug 01; 19(2):2220630. PubMed ID: 37282614 [Abstract] [Full Text] [Related]
7. Vogt-Koyanagi-Harada disease following BCG vaccination and tuberculosis. Dogan B, Erol MK, Cengiz A. Springerplus; 2016 Aug 01; 5():603. PubMed ID: 27247899 [Abstract] [Full Text] [Related]
10. Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report. Kikuchi R, Kawagoe T, Hotta K. BMC Ophthalmol; 2020 Jun 24; 20(1):252. PubMed ID: 32580711 [Abstract] [Full Text] [Related]
11. A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma. Brambati M, Giuffrè C, Marchese A, Bandello F, Modorati GM, Miserocchi E. Eur J Ophthalmol; 2022 Jan 24; 32(1):NP109-NP113. PubMed ID: 32998540 [Abstract] [Full Text] [Related]